Wheeler DA. Weight loss and disease progression in HIV infection. AIDS Read. 1999 Aug. 9(5):347-53. [Medline].
Koethe JR, Heimburger DC. Nutritional aspects of HIV-associated wasting in sub-Saharan Africa. Am J Clin Nutr. 2010 Apr. 91(4):1138S-1142S. [Medline].
Pienaar M, van Rooyen FC, Walsh CM. Reported health, lifestyle and clinical manifestations associated with HIV status in people from rural and urban communities in the Free State Province, South Africa. South Afr J HIV Med. 2017. 18 (1):465. [Medline]. [Full Text].
de Pee S, Semba RD. Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings. Food Nutr Bull. 2010 Dec. 31(4):S313-44. [Medline].
Mehta S, Manji KP, Young AM, Brown ER, Chasela C, Taha TE. Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women. Am J Clin Nutr. 2008 Jun. 87(6):1639-49. [Medline].
Chandra RK. Nutrition and immunology: from the clinic to cellular biology and back again. Proc Nutr Soc. 1999 Aug. 58(3):681-3. [Medline].
Roubenoff R, Grinspoon S, Skolnik PR, Tchetgen E, Abad L, Spiegelman D. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol Endocrinol Metab. 2002 Jul. 283(1):E138-45. [Medline].
Gelato M, McNurlan M, Freedland E. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment. Clin Ther. 2007 Nov. 29(11):2269-88. [Medline].
Friis H, Michaelsen KF. Micronutrients and HIV infection: a review. Eur J Clin Nutr. 1998 Mar. 52(3):157-63. [Medline].
Beisel WR. Nutrition in pediatric HIV infection: setting the research agenda. Nutrition and immune function: overview. J Nutr. 1996 Oct. 126(10 Suppl):2611S-2615S. [Medline].
Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med. 1996. 21(5):641-9. [Medline].
Bendich A. Antioxidant micronutrients and immune responses. Ann N Y Acad Sci. 1990. 587:168-80. [Medline].
Tang AM, Graham NM, Chandra RK, Saah AJ. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr. 1997 Feb. 127(2):345-51. [Medline].
Campa A, Shor-Posner G, Indacochea F, Zhang G, Lai H, Asthana D. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15. 20(5):508-13. [Medline].
Rodriguez JF, Cordero J, Chantry C, González S, Rivera C, Febo I. Plasma glutathione concentrations in children infected with human immunodeficiency virus. Pediatr Infect Dis J. 1998 Mar. 17(3):236-41. [Medline].
Koethe JR, Jenkins CA, Shepherd BE, Stinnette SE, Sterling TR. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Clin Infect Dis. 2011 Nov. 53(9):952-60. [Medline].
Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE. Influence of obesity on immune function. J Am Diet Assoc. 1999 Mar. 99(3):294-9. [Medline].
Fawzi WW, Mbise RL, Hertzmark E, Fataki MR, Herrera MG, Ndossi G. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis J. 1999 Feb. 18(2):127-33. [Medline].
Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004 Jul 1. 351(1):23-32. [Medline].
Thakur HS, Gottapu GS, Kadali SP, Kulkarni B, Mamidi RS. Effect of Nutrition Supplementation in Children Living with HIV at ART Centre. Indian J Pediatr. 2016 Mar. 83 (3):232-7. [Medline].
Baveewo S, Ssali F, Karamagi C, Kalyango JN, Hahn JA, Ekoru K. Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda. PLoS One. 2011. 6(5):e19089. [Medline].
Schwenk A, Steuck H, Kremer G. Oral supplements as adjunctive treatment to nutritional counseling in malnourished HIV-infected patients: randomized controlled trial. Clin Nutr. 1999 Dec. 18(6):371-4. [Medline].
Rabeneck L, Palmer A, Knowles JB, Seidehamel RJ, Harris CL, Merkel KL. A randomized controlled trial evaluating nutrition counseling with or without oral supplementation in malnourished HIV-infected patients. J Am Diet Assoc. 1998 Apr. 98(4):434-8. [Medline].
Berneis K, Battegay M, Bassetti S, Nuesch R, Leisibach A, Bilz S. Nutritional supplements combined with dietary counselling diminish whole body protein catabolism in HIV-infected patients. Eur J Clin Invest. 2000 Jan. 30(1):87-94. [Medline].
Malete L, Mokgatlhe L, Nnyepi M, Jackson J, Wen F, Bennink M, et al. Effects of a High Protein Food Supplement on Physical Activity, Motor Performance and Health Related Quality of Life of HIV Infected Botswana Children on Anti-Retroviral Therapy (ART). AIMS Public Health. 2017. 4 (3):258-277. [Medline]. [Full Text].
Stack JA, Bell SJ, Burke PA, Forse RA. High-energy, high-protein, oral, liquid, nutrition supplementation in patients with HIV infection: effect on weight status in relation to incidence of secondary infection. J Am Diet Assoc. 1996 Apr. 96(4):337-41. [Medline].
O'Brien K, Nixon S, Tynan AM, Glazier R. Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev. 2010 Aug 4. CD001796. [Medline].
Grinspoon S, Corcoran C, Stanley T, Katznelson L, Klibanski A. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab. 1998 Dec. 83(12):4251-6. [Medline].
Kong A, Edmonds P. Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis. Lancet Infect Dis. 2002 Nov. 2(11):692-9. [Medline].
Johns K, Beddall MJ, Corrin RC. Anabolic steroids for the treatment of weight loss in HIV-infected individuals. Cochrane Database Syst Rev. 2005. (4):CD005483. [Medline].
Berenstein EG, Ortiz Z. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev. 2005. (2):CD004310. [Medline].
Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Tchekmedyian NS. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med. 1994 Sep 15. 121(6):393-9. [Medline].
Oster MH, Enders SR, Samuels SJ, Cone LA, Hooton TM, Browder HP. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med. 1994 Sep 15. 121(6):400-8. [Medline].
Kontula K, Paavonen T, Luukkainen T, Andersson LC. Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol. 1983 May 1. 32(9):1511-8. [Medline].
Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M. Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Arch Intern Med. 1997 Aug 11-25. 157(15):1651-6. [Medline].
